Evidence map›Paper›PMID 39334967›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Long-Term Clinical and Ecological Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem-Resistant

Teresa López-Viñau, Montserrat Muñoz-Rosa, Lidia Mª Ruiz-Lara, Lucrecia García-Martínez, Isabel Machuca, Irene Gracia-Ahufinger, Rafael Ruiz Montero, Juan José Castón, Ángela Cano, Elisa Ruiz-Arabi and 4 more

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Antibiotic resistance inFrontiers in microbiology · 2026
    Review
  2. Article
  3. Article
  4. Global burden and trends ofFrontiers in public health · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Teresa López-ViñauPharmacy Unit, Reina Sofia University Hospital, 14004 Cordoba, Spain.ORCID 0000-0003-3493-6969
Montserrat Muñoz-RosaMicrobiology Unit, Reina Sofia University Hospital, Maimonides. Biomedical Research Institute of Cordoba (IMIBIC), 14004 Cordoba, Spain.
Lidia Mª Ruiz-LaraPharmacy Unit, Reina Sofia University Hospital, 14004 Cordoba, Spain.ORCID 0009-0004-4647-5252
Lucrecia García-MartínezPharmacy Unit, Reina Sofia University Hospital, 14004 Cordoba, Spain.ORCID 0000-0003-1181-7991
Isabel MachucaInfectious Diseases Unit, Reina Sofia University Hospital, Maimonides. Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba (UCO), 14004 Cordoba, Spain.
Irene Gracia-AhufingerCentro de investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0001-7714-6620
Rafael Ruiz MonteroPreventive Medicine and Public Health Unit, Reina Sofia University Hospital, Maimonides. Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba (UCO), 14004 Cordoba, Spain.ORCID 0000-0002-9113-6493
Juan José CastónInfectious Diseases Unit, Reina Sofia University Hospital, Maimonides. Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba (UCO), 14004 Cordoba, Spain.ORCID 0000-0002-7477-2033
Ángela CanoInfectious Diseases Unit, Reina Sofia University Hospital, Maimonides. Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba (UCO), 14004 Cordoba, Spain.ORCID 0000-0002-7801-9778
Elisa Ruiz-ArabiInfectious Diseases Unit, Reina Sofia University Hospital, Maimonides. Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba (UCO), 14004 Cordoba, Spain.ORCID 0000-0002-5833-4834
José Ramón Del PradoPharmacy Unit, Reina Sofia University Hospital, 14004 Cordoba, Spain.
Inmaculada SalcedoPreventive Medicine and Public Health Unit, Reina Sofia University Hospital, Maimonides. Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba (UCO), 14004 Cordoba, Spain.ORCID 0000-0002-0864-6856
Luis Martínez-MartínezCentro de investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-6091-4045
Julián Torre-CisnerosInfectious Diseases Unit, Reina Sofia University Hospital, Maimonides. Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba (UCO), 14004 Cordoba, Spain.ORCID 0000-0003-1529-6302

Funding

Center of Biomedical Investigation Network for Infectious Diseases (CIBERINFEC) CB21/13/00049, CB21/13/00012, CB21/13/00006Instituto de Salud Carlos III PI21/01199
6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

antimicrobial resistanceantimicrobial stewardship programcarbapenem-resistant infectionscarbapenem-resistant Klebsiella pneumoniaecarbapenemsintervention

Identifiers

PMID39334967
PMCPMC11429328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.